WebThrombocytopaenia, but not neutropaenia, is described as a possible or probable adverse … WebFor the secondary analysis 227 VRE isolates were evaluated and 62% had daptomycin MICs of 3-4 mg/L. Each daptomycin MIC group had a similar incidence of prior vancomycin exposure. Conclusions: Also, prior vancomycin exposure did not appear to influence daptomycin MICs.
Daptomycin versus linezolid for treatment of vancomycin-resistant …
WebDec 11, 2024 · Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces roseosporus. Daptomycin is used to treat various bacterial infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). ... The incidence of myopathy has been shown … WebOct 1, 2012 · described case of daptomycin-induced thrombocytopenia. W e report a case of daptomycin-induced immune thrombo- cytopenia observed in a 64-year-old man admitted to our intensive care unit... flyerswesley
Daptomycin and Thrombocytopenia, a phase IV clinical study of …
WebMar 7, 2024 · Daptomycin is a lipopeptide antimicrobial with activity against gram-positive … WebMar 31, 2024 · Clinicians should be alert to the risk of thrombotic diseases in ITP treatment, and early prevention or appropriate anticoagulant treatment should be selected, especially for patients with high risk. Rationale: Immune thrombocytopenia (ITP) is an autoimmune disease with an increased risk of bleeding. However, in recent years, it has been reported … WebNov 30, 2024 · DITP is a life-threatening clinical syndrome that is associated with a high risk of hemorrhage. A review of 247 case reports of DITP found incidence rates of major and fatal bleeding of 9% and 0.8%, respectively. Thrombocytopenia characteristically occurs ∼5 to 10 days after initial drug exposure, with median nadir platelet counts of <20 × ... flyers wels facebook